2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow disufenton sodium: new trials by email Literature Review of disufenton sodium trials Research Report on disufenton sodium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma OKN-007, Temozolomide (TMZ) - Recurrent Malignant Glioma, Brain Glioblastoma | Phase 2 | Completed | Oblato, Inc. | 57 | 2020-06-12 | 2025-08-12 |
| Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke NXY-059 - Intracerebral Hemorrhage | Phase 2 | Completed | AstraZeneca | 600 | 2004-08-01 | 2013-01-04 |
Cataplexy (1) · Cerebral Hemorrhage (1) · Glioma (1) · Hemorrhage (1) · Stroke (1)
AstraZeneca (1) · Oblato, Inc. (1)
United States (2)